Researchers from Japan have found a way to stop the development of amyloid-beta fibers, which are associated with Alzheimer's disease, using a new antibody that "locks" the fibers and prevents their further progress in the brain. This breakthrough may form the basis for the development of treatments that will slow down the progression of the disease and improve the quality of life of patients, SciTecDaily reported.
During the study, it was found that antibody 4396C is able to bind to the ends of amyloid-beta fibers when they are in a "delayed" state and prevent their further growth.
This discovery offers a new therapeutic approach that works to stop the development of Alzheimer's, a degenerative disease that causes cognitive decline and memory loss.
The researchers see this discovery as a breakthrough for the development of new drugs, which can treat not only Alzheimer's but also other diseases related to the accumulation of proteins in the brain, preventing lasting damage to brain functions.
As we know, Alzheimer's disease is one of the most common neurodegenerative diseases in the world, which mainly affects the elderly. It manifests itself in the gradual and irreversible degeneration of the brain cells, and is accompanied by memory loss, a decrease in cognitive abilities and a gradual impairment of the quality of life.